The cardiac cell cycle, pocket proteins, and p300

Arany, 1995, A family of transcriptional adaptor proteins targeted by the E1A oncoprotein, Nature, 374, 81, 10.1038/374081a0 Braun, 1992, Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5, Genes Dev, 6, 888, 10.1101/gad.6.5.888 Caruso, 1993, Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus EIA oncoprotein, Oncogene, 8, 267 Crescenzi, 1995, Mitotic cycle reactivation in terminally differentiated cells by adenovirus infection, J Cell Physiol, 162, 26, 10.1002/jcp.1041620105 DeLeon, 1994, Cardiac and skeletal myopathy in beta myosin heavy-chain simian virus 40 tsA58 transgenic mice, 91, 519 Dyson, 1992, Adenovirus EIA targets key regulators of cell proliferation, Cancer Surv, 12, 161 Eckner, 1994, Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (P300) reveals a protein with properties of a transcriptional adaptor, Genes Dev, 8, 869, 10.1101/gad.8.8.869 Elledge, 1994, Cdk inhibitors: on the threshold of checkpoints and development, Curr Opin Cell Biol, 6, 847, 10.1016/0955-0674(94)90055-8 Endo, 1986, Transcriptional and posttranscriptional control of c-myc during myogenesis: Its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype, Mol Cell Biol, 6, 1412, 10.1128/MCB.6.5.1412 Enkemann, 1990, Adenovirus 5 E1A represses muscle-specific enhancers and inhibits expression of the myogenic regulatory factor genes, MyoD1 and myogenin, Cell Growth Differ, 1, 375 Field, 1988, Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice, Science, 239, 1029, 10.1126/science.2964082 Gottlieb, 1994, Reperfusion injury induces apoptosis in rabbit cardiomyocytes, J Clin Invest, 94, 1621, 10.1172/JCI117504 Gu, 1993, Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation, Cell, 72, 309, 10.1016/0092-8674(93)90110-C Halevy, 1995, Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD, Science, 267, 1018, 10.1126/science.7863327 Katz, 1992, Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 Tantigen transgenes, Am J Physiol, 262, H1867 Kim, 1994, Tumor suppressor gene expression during normal and pathological myocardial growth, J Biol Chem, 269, 22,607, 10.1016/S0021-9258(17)31689-7 Kirshenbaum, 1995, Adenovirus EIA represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains, J Biol Chem, 270, 7791, 10.1074/jbc.270.14.7791 Kirshenbaum, 1993, Highly efficient gene transfer to adult rat ventricular myocytes by recombinant adenovirus, J Clin Invest, 92, 381, 10.1172/JCI116577 Lanson, 1992, Gene expression and atrial natriuretic factor processing and secretion in cultured AT-1 cardiac myocytes, Circulation, 85, 1835, 10.1161/01.CIR.85.5.1835 Lee, 1995, Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution, Genes Dev, 9, 639, 10.1101/gad.9.6.639 Lilly, 1995, Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila, Science, 267, 688, 10.1126/science.7839146 Lundblad, 1995, Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP, Nature, 374, 85, 10.1038/374085a0 Matsuoka, 1995, p51KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene, Genes Dev, 9, 650, 10.1101/gad.9.6.650 Matsushime, 1994, D-type cyclin-dependent kinase activity in mammalian cells, Mol Cell Biol, 14, 2066, 10.1128/MCB.14.3.2066 Missero, 1995, Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation, 92, 5451 Moran, 1993, Interaction of adenoviral proteins with pRB and p53, FASEB J, 7, 880, 10.1096/fasebj.7.10.8344487 Moran, 1994, Mammalian cell growth controls reflected through protein interactions with the adenovirus E1A gene products, Semin Virol, 5, 327, 10.1006/smvy.1994.1037 Mymryk, 1992, Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300-kDa cellular protein, Mol Biol Cell, 3, 1107, 10.1091/mbc.3.10.1107 Nevins, 1992, E2F: a link between the Rb tumor suppressor protein and viral oncoproteins, Science, 258, 424, 10.1126/science.1411535 Olson, 1994, bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out, Genes Dev, 8, 1, 10.1101/gad.8.1.1 Parker, 1995, p53-independent expression of p21(Cip)1 in muscle and other terminally differentiating cells, Science, 267, 1024, 10.1126/science.7863329 Rao, 1994, Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators, Mol Cell Biol, 14, 5259, 10.1128/MCB.14.8.5259 Sartorelli, 1992, Myocardial activation of the human cardiac α-actin promoter by helixloop-helix proteins, 89, 4047 Schneider, 1994, Reversal of terminal differentiation mediated by p107 in Rb(-/-) muscle cells, Science, 264, 1467, 10.1126/science.8197461 Sen, 1988, Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen, J Biol Chem, 263, 19,132, 10.1016/S0021-9258(18)37400-3 Sherr, 1995, Inhibitors of mammalian G(1) cyclin-dependent kinases, Genes Dev, 9, 1149, 10.1101/gad.9.10.1149 Shin, 1995, Multiple changes in E2F function and regulation occur upon muscle differentiation, Mol Cell Biol, 15, 2252, 10.1128/MCB.15.4.2252 Skapek, 1995, Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase, Science, 267, 1022, 10.1126/science.7863328 Steinhelper, 1990, Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice, Am J Physiol, 259, H1826 Tam, 1995, Cardiac myocyte terminal differentiation, 72 Taylor, 1993, E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helixloop-helix proteins, Mol Cell Biol, 13, 4714, 10.1128/MCB.13.8.4714 Vairo, 1995, Functional interaction between E2F-4 and p 130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members, Genes Dev, 9, 869, 10.1101/gad.9.7.869 Wang, 1995, Regulation of cyclin and p34CDC2 expression during terminal differentiation of C2C12 myocytes, Biochem Biophys Res Commun, 206, 82, 10.1006/bbrc.1995.1012 Webster, 1988, Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters, Nature, 332, 553, 10.1038/332553a0 Weinberg, 1995, The retinoblastoma protein and cell cycle control, Cell, 81, 323, 10.1016/0092-8674(95)90385-2 Weintraub, 1993, The MyoD family and myogenesis: redundancy, networks, and thresholds, Cell, 75, 1241, 10.1016/0092-8674(93)90610-3 Weintraub, 1992, Retinoblastoma protein switches the E2F site from positive to negative element, Nature, 358, 259, 10.1038/358259a0 Yoshizumi, 1995, Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts, J Clin Invest, 95, 2275, 10.1172/JCI117918 Yu, 1992, Human myocyte-specific enhancer factor-2 comprises a group of tissue-restricted MADS box transcription factors, Genes Dev, 6, 1783, 10.1101/gad.6.9.1783